Deweyert, Andrew
Iredale, Erin
Xu, Hu
Wong, Eugene
Schmid, Susanne
Hebb, Matthew O. http://orcid.org/0000-0002-9582-4314
Article History
Received: 29 January 2019
Accepted: 4 March 2019
First Online: 9 March 2019
Compliance with ethical standards
:
: Matthew O. Hebb and Susanne Schmid are inventors on the following patent applications that are assigned to “London Health Sciences Centre Research Inc.” (the applicant): PCT/CA2016/050556 entitled “Intratumoral Modulation Therapy” and corresponding national phase applications in Canada, United States, Europe and China. The authors have no other competing interests.
: All human DIPG cells were obtained from Dr. Michelle Monje (Stanford University) in accordance with the ethical standards of the Institutional Review Board (IRB) at Stanford University and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: All human tissues were obtained with informed consent for research purposes.